Apyx Medical (NASDAQ:APYX) issued its quarterly earnings results on Wednesday. The company reported ($0.10) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.10), Briefing.com reports. The company had revenue of $5.93 million for the quarter, compared to analysts’ expectations of $5.95 million. Apyx Medical had a negative return on equity of 6.32% and a net margin of 184.40%. The firm’s revenue for the quarter was up 62.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.09) earnings per share. Apyx Medical updated its FY 2019 guidance to EPS.
Shares of APYX stock opened at $7.05 on Friday. The firm has a market capitalization of $232.76 million, a P/E ratio of -41.62 and a beta of 0.38. Apyx Medical has a twelve month low of $2.75 and a twelve month high of $8.89.
Separately, Piper Jaffray Companies upped their price target on Apyx Medical to $10.00 and gave the stock an “overweight” rating in a research note on Monday, February 11th.
TRADEMARK VIOLATION NOTICE: “Apyx Medical (APYX) Issues Quarterly Earnings Results, Meets Expectations” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/4223232/apyx-medical-apyx-issues-quarterly-earnings-results-meets-expectations.html.
Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide. The company markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. Its Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma.
Recommended Story: Market Capitalization in the Stock Market
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.